Certolizumab pegol

Details

Files
Generic Name:
Certolizumab pegol
Project Status:
Complete
Therapeutic Area:
Arthritis, rheumatoid
Manufacturer:
UCB Pharma Canada Inc.
Brand Name:
Cimzia
Project Line:
Reimbursement Review
Project Number:
SR0175-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Arthritis, rheumatoid
Recommendation Type:
Do not list
Final Recommendation: